Tabula Rasa Healthcare

Tabula Rasa Healthcare, Inc. is a healthcare technology company, which engages in the development of solutions designed for pharmacists, providers, and patients to optimize medication regimens. It operates through the following segments: CareVention HealthCare and MedWise HealthCare. The CareVention HealthCare segment provides services, PACE, which is a center for Medicare & Medicaid services, or CMS, sponsored program providing medical and social services. Its brands include CareKinesis, Capstone Risk Adjustment Services, PACElogic, TruChart, PeakTPA, PersonifilRx, and Pharmastar. The MedWise HealthCare segment provides Medication Therapy Management, or MTM, software and services for Medicare, Medicaid, and commercial health plans, and also provides a cloud-based patient engagement software and services. It offers cloud-based software and clinical pharmacist services through its brands, including MedWise, SinfoníaRx, RxCompanion, PrescribeWellness, and DoseMeRx. The company was founded by Calvin H. Knowlton, Orsula V. Knowlton, and Michael Greenhalgh in April 2009 and is headquartered in Moorestown, NJ.

Earnings data Q4 2019

Earnings data Q1 2020

Earnings data Q2 2020

Earnings data Q3 2020

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q2 2024

Tabula Rasa HealthCare reports robust Q4 growth and strategic investments

Tabula Rasa HealthCare's Q4 2022 performance reflects strong revenue growth and strategic initiatives to enhance profitability.
While facing challenges in technology-enabled solutions revenue and execution risks, the company is well-positioned for growth.
Opportunities in automation investments and MedWise platform expansion offer avenues for sustained revenue growth and market impact.

Tabula Rasa HealthCare (TRHC) excels in Q1 2023 earnings, eyes expansion

Tabula Rasa HealthCare (TRHC) delivered strong financial performance in Q1 2023, driven by revenue growth, profitability focus, and strategic initiatives.
The company faces challenges from drug price inflation and contract turnover impact but is well-positioned for future expansion and market penetration.
TRHC's emphasis on customer-centric strategies, PACE program growth, and efficient resource management sets the stage for continued success and revenue growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tabula Rasa provides state-of-the-art medication management through a combination of technology, science and services that reduces costs, improves the quality of care and decreases the risks associated with ineffective medication plans.

AnewHealth provides transformative pharmacy solutions that elevate care and help providers and payers overcome the unique challenges of caring for the most at-risk patients in healthcare AnewHealth provides transformative pharmacy solutions that elevate care and help providers and payers overcome the unique challenges of caring for the most at-risk patients in healthcare

ExactCare and Tabula Rasa HealthCare Rebrand Combined Organization as AnewHealth

CLEVELAND, Nov. 06, 2023 (GLOBE NEWSWIRE) -- ExactCare®, a national provider of medication management and comprehensive long-term pharmacy services and a Nautic Partners portfolio company, today announced that the acquisition of Tabula Rasa HealthCare, Inc.®, a leading healthcare company advancing personalized, comprehensive care for value-based care organizations, is complete.

ExactCare and Tabula Rasa HealthCare Business Combination Closes, Creating a Leading, Independent Value-Based Pharmacy Management Company for Patients with the Most Complex Needs

MOORESTOWN, N.J. , Oct. 31, 2023 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® ("TRHC" or the "Company") (NASDAQ: TRHC), a leading healthcare company advancing personalized, comprehensive care for value-based organizations, today announced that its stockholders approved the previously announced acquisition by Nautic Partners ("Nautic"), following which TRHC is expected to combine with ExactCare Pharmacy, a portfolio company of Nautic.

Tabula Rasa HealthCare Stockholders Approve Acquisition by Nautic Partners

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Tabula Rasa HealthCare, Inc. (NasdaqGM: TRHC) to Nautic Partners. Under the terms of the proposed transaction, shareholders of Tabula will receive $10.50 in cash for each share of Tabula that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whethe.

TABULA RASA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Tabula Rasa HealthCare, Inc. - TRHC

PHILADELPHIA , Aug. 9, 2023 /PRNewswire/ -- Kaskela Law LLC announces that it is investigating the fairness of the proposed buyout of Tabula Rasa HealthCare, Inc. ("Tabula Rasa") (NASDAQ: TRHC) shareholders by private equity firm Nautic Partners ("Nautic") at $10.50 per share . Following the closing of the proposed transaction, Tabula Rasa investors will be cashed out of their investment position and the company's shares will no longer be publicly traded.

TABULA RASA SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation into Fairness of $10.50 Per Share Buyout Agreement - TRHC

The company also announced improved revenue in its second-quarter earnings. The deal is expected to be completed by the fourth quarter of 2023.

Why Shares of Tabula Rasa HealthCare Are Soaring Monday

Although the revenue and EPS for Tabula Rasa Healthcare (TRHC) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Compared to Estimates, Tabula Rasa Healthcare (TRHC) Q2 Earnings: A Look at Key Metrics

Tabula Rasa Healthcare (TRHC) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of a loss of $0.14 per share. This compares to loss of $0.32 per share a year ago.

Tabula Rasa Healthcare (TRHC) Q2 Earnings and Revenues Surpass Estimates

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC) to Nautic Partners for $10.50 in cash per share is fair to Tabula Rasa shareholders. Halper Sadeh encourages Tabula Rasa shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concerns wheth.

TRHC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Tabula Rasa Healthcare, Inc. Is Fair to Shareholders

Tabula Rasa HealthCare Inc shares were 30% higher in premarket trading after news that the healthcare company is to be acquired by private-equity firm Nautic Partners. The all-cash deal is for approximately $570 million, including debt of around $262 million.

Tabula Rasa HealthCare shares surge 30% in premarket trade after acquisition by private equity firm

Continued Strong Organic Revenue Growth of 24% Second Quarter Adjusted EBITDA of $6.3 Million Increased More Than 3x Compared to Second Quarter 2022 MOORESTOWN, N.J. , Aug. 7, 2023 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (Nasdaq:TRHC) ("TRHC" or the "Company"), a leading healthcare company advancing personalized, comprehensive care for value-based care organizations, today reported financial results for the second quarter ended June 30, 2023.

Tabula Rasa HealthCare Reports Second Quarter 2023 Financial Results

$10.50 Per Share All-Cash Transaction Represents a Significant Premium for Tabula Rasa Stockholders Combination of Two Highly Complementary Companies to Benefit Patients, Providers and Payers with First of its Kind Risk Management Platform in Pharmacy Care Expands the Reach of Tabula Rasa's MedWise Technology Platform to Multiple Provider and Payer Markets MOORESTOWN, N.J. , Aug. 7, 2023 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® ("TRHC," "Tabula Rasa" or the "Company") (NASDAQ: TRHC), a leading healthcare company advancing personalized, comprehensive care for value-based care organizations, today announced it has entered into a definitive agreement (the "Agreement") to be acquired by Nautic Partners ("Nautic") for $10.50 in cash per share and will combine with ExactCare Pharmacy ("ExactCare"), a portfolio company of Nautic.

Tabula Rasa and ExactCare to Combine to Create a Leading, Independent Pharmacy Care Management Company That Services Patients with the Most Complex Needs

MOORESTOWN, N.J. , July 25, 2023 /PRNewswire/ -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), will hold a conference call and webcast to discuss its second quarter 2023 financial results Tuesday, August 8, 2023 at 8:30 a.m.

Tabula Rasa HealthCare Schedules Second Quarter 2023 Earnings Conference Call

Tabula Rasa Healthcare (TRHC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Tabula Rasa Healthcare (TRHC) Moves 6.3% Higher: Will This Strength Last?

Tabula Rasa Healthcare (TRHC) Surges 7.8%: Is This an Indication of Further Gains?

MOORESTOWN, N.J. , May 17, 2023 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ: TRHC), a leading healthcare company advancing personalized, comprehensive care for value-based care organizations, today announced that Mountain Empire PACE, a Program of All-Inclusive Care for the Elderly (PACE) in rural Virginia, has signed agreements with TRHC for personalized pharmacy services and pharmacy benefit management, expanding their existing partnership.

Mountain Empire PACE Signs with TRHC for Expanded Services

Tabula Rasa Healthcare (TRHC) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to loss of $0.33 per share a year ago.

Tabula Rasa Healthcare (TRHC) Reports Q1 Loss, Tops Revenue Estimates

First Quarter Results Show Benefits of Consistent Execution on Financial and Strategic Objectives First Quarter Revenue Growth of 32% Compared to First Quarter 2022 Raises Full Year 2023 Revenue and Adjusted EBITDA Guidance MOORESTOWN, N.J. , May 8, 2023 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (Nasdaq:TRHC) ("TRHC" or the "Company"), a leading healthcare technology company advancing the safe use of medications, today reported financial results for the first quarter ended March 31, 2023.

Tabula Rasa HealthCare Reports First Quarter 2023 Financial Results

Tabula Rasa Healthcare (TRHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Will Tabula Rasa Healthcare (TRHC) Report Negative Earnings Next Week? What You Should Know

MOORESTOWN, N.J. , April 26, 2023 /PRNewswire/ -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), will hold a conference call and webcast to discuss its first quarter 2023 financial results Tuesday, May 9, 2023 at 8:30 a.m.

Tabula Rasa HealthCare Schedules First Quarter 2023 Earnings Conference Call

Appoints Brian Adams as President and Chief Executive Officer and a Member of the Board of Directors, Effective Immediately.

Tabula Rasa HealthCare Provides Corporate Updates

Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC ) Q4 2022 Earnings Conference Call March 7, 2023 8:30 AM ET Company Participants Frank Sparacino - Senior Vice President, Investor Relations and Corporate Development Brian Adams - President and Interim Chief Executive Officer Tom Cancro - Chief Financial Officer Conference Call Participants Stephanie David - SVB Securities Craig Jones - Stifel Jessica Tassan - Piper Sandler Operator Good day and thank you for standing by. Welcome to the Tabula Rasa HealthCare's Fourth Quarter and Full-Year 2022 Earnings Conference Call.

Tabula Rasa HealthCare, Inc. (TRHC) Q4 2022 Earnings Call Transcript

Tabula Rasa Healthcare (TRHC) delivered earnings and revenue surprises of -200% and 0.22%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Tabula Rasa Healthcare (TRHC) Reports Q4 Loss, Tops Revenue Estimates

Fourth Quarter Concludes Successful Transformational Year, With Company Sharpening Focus and Laying a Foundation for Sustainable, Profitable Growth Recently Completed Sales of SinfoníaRx and DoseMe Shares Full Year 2023 Revenue Guidance and Adjusted EBITDA Guidance MOORESTOWN, N.J. , March 6, 2023 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (Nasdaq: TRHC) ("TRHC" or the "Company"), a leading healthcare technology company advancing the safe use of medications, today reported financial results for the fourth quarter and full year ended December 31, 2022.

Tabula Rasa HealthCare Reports Fourth Quarter and Full Year 2022 Financial Results

NEW YORK , March 3, 2023 /PRNewswire/ -- Cureatr, a national, value-based medication management services company improving quality and reducing total cost of care, announces it has acquired the SinfoníaRx business, an industry leader in medication therapy management (MTM), from Tabula Rasa HealthCare, Inc.® (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications. This acquisition will round out Cureatr's existing clinical pharmacy services to include MTM and expand the company's scale with a larger team of clinical pharmacists, pharmacy technicians, and pharmacy interns serving health plans, pharmacy benefit managers (PBMs), and patients across the country.

News for Tabula Rasa Healthcare Stock (TRHC)